987116043	987116043	CD	B-NP	O
|	|	NNP	I-NP	O
NHS	NHS	NNP	I-NP	O
|	|	VBD	B-VP	O
78869064	78869064	CD	B-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
7967976	7967976	CD	B-NP	O
|	|	CC	I-NP	O
7/25/2005	7/25/2005	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
PNEUMONIA	PNEUMONIA	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
1/24/2005	1/24/2005	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/15/2005	10/15/2005	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
DEMARCUS	DEMARCUS	NNP	B-NP	O
PHILIP	PHILIP	NNP	I-NP	O
TARRANTS	TARRANTS	NNP	I-NP	O
MD	MD	NNP	I-NP	O
ADMITTING	ADMITTING	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
Pneumonia	Pneumonia	NNP	B-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
NSTEMI	NSTEMI	NN	B-NP	O
,	,	,	O	O
pneumonia	pneumonia	NN	B-NP	O
.	.	.	O	O

CHIEF	CHIEF	NN	B-NP	B-protein
COMPLAINT	COMPLAINT	NN	I-NP	O
:	:	:	O	O
Right	Right	NN	B-NP	O
hip	hip	NN	I-NP	O
and	and	CC	O	O
knee	knee	NN	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
76-year-old	76-year-old	JJ	I-NP	O
woman	woman	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
insulin-dependent	insulin-dependent	JJ	B-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
three-vessel	three-vessel	JJ	B-NP	O
CAD	CAD	NN	I-NP	O
,	,	,	O	O
lung	lung	NN	B-NP	O
cancer	cancer	NN	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
lobectomy	lobectomy	NN	I-NP	O
in	in	IN	B-PP	O
October	October	NNP	B-NP	O
2003	2003	CD	I-NP	O
who	who	WP	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
was	be	VBD	B-VP	O
getting	get	VBG	I-VP	O
out	out	IN	B-PP	O
of	of	IN	B-PP	O
bed	bed	NN	B-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
and	and	CC	O	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
mechanical	mechanical	JJ	I-NP	O
fall	fall	NN	I-NP	O
due	due	JJ	B-PP	O
to	to	TO	B-PP	O
right	right	JJ	B-NP	O
leg	leg	NN	I-NP	O
weakness	weakness	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
pale	pale	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
diaphoretic	diaphoretic	JJ	I-ADJP	O
at	at	IN	B-PP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
recently	recently	RB	I-VP	O
noticed	notice	VBN	I-VP	O
an	an	DT	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
,	,	,	O	O
severe	severe	JJ	B-NP	O
dyspnea	dyspnea	NN	I-NP	O
on	on	IN	B-PP	O
exertion	exertion	NN	B-NP	O
,	,	,	O	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
loss	loss	NN	I-NP	O
of	of	IN	B-PP	O
consciousness	consciousness	NN	B-NP	O
,	,	,	O	O
trauma	trauma	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
prodrome	prodrome	NN	B-NP	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
this	this	DT	B-NP	O
mechanical	mechanical	JJ	I-NP	O
fall	fall	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
denied	deny	VBD	B-VP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
to	to	TO	B-PP	O
OH	OH	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
left	leave	VBN	I-VP	O
shoulder	should	JJR	B-NP	O
pain	pain	NN	I-NP	O
and	and	CC	O	O
complained	complain	VBD	B-VP	O
of	of	IN	B-PP	O
right	right	JJ	B-NP	B-protein
scapular	scapular	JJ	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
room	room	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
recently	recently	RB	I-VP	O
discharged	discharge	VBN	I-VP	O
from	from	IN	B-PP	O
FGH	FGH	NN	B-NP	B-protein
after	after	IN	B-PP	O
admission	admission	NN	B-NP	O
for	for	IN	B-PP	O
herniated	herniate	VBN	B-NP	O
disc	disc	NN	I-NP	O
at	at	IN	B-PP	O
L2	L2	NN	B-NP	B-DNA
and	and	CC	I-NP	O
L3	L3	NN	I-NP	B-DNA
with	with	IN	B-PP	O
right	right	JJ	B-NP	O
nerve	nerve	NN	I-NP	O
root	root	NN	I-NP	O
impingement	impingement	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
room	room	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
was	be	VBD	B-VP	O
remarkable	remarkable	JJ	B-ADJP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
left	left	JJ	I-NP	O
lower	low	JJR	I-NP	O
lobe	lobe	NN	I-NP	O
pneumonia	pneumonia	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
elevated	elevated	JJ	I-NP	O
troponin	troponin	NN	I-NP	O
at	at	IN	B-PP	O
0.19	0.19	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
EKG	EKG	NN	I-NP	B-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
room	room	NN	I-NP	O
showed	show	VBD	B-VP	O
0.5	0.5	CD	B-NP	O
mm	mm	NN	I-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
ST	ST	JJ	B-NP	O
depressions	depression	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
inferolateral	inferolateral	JJ	I-NP	O
leads	lead	NNS	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
at	at	IN	B-PP	O
baseline	baseline	NN	B-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

IDDM	IDDM	NN	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

CAD	CAD	NN	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Hyperlipidemia	Hyperlipidemia	NN	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Hypertension	Hypertension	NN	B-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Glaucoma	Glaucoma	NN	B-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

PMR	PMR	NN	B-NP	B-protein
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Spinal	Spinal	JJ	B-NP	O
stenosis	stenosis	NN	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Disc	Disc	NN	B-NP	O
herniation	herniation	NN	I-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Upper	Upper	IN	B-PP	O
GI	GI	NN	B-NP	O
bleed	bleed	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
AVM	AVM	NN	I-NP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

Lower	Low	JJR	B-NP	O
GI	GI	NN	I-NP	B-protein
bleed	bleed	NN	I-NP	I-protein
11	11	CD	I-NP	I-protein
.	.	.	O	O

Iron	Iron	NN	B-NP	O
deficiency	deficiency	NN	I-NP	O
anemia	anemia	NN	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Atorvastatin	Atorvastatin	IN	B-PP	O
40	40	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
2	2	CD	I-NP	O
.	.	.	O	O

Lisinopril	Lisinopril	NNP	B-NP	O
60	60	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
3	3	CD	I-NP	O
.	.	.	O	O

Metformin	Metformin	NN	B-NP	B-protein
850	850	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
b.i.d.	b.i.d.	RB	B-NP	I-protein
4	4	CD	I-NP	I-protein
.	.	.	O	O

NPH	NPH	NN	B-NP	B-protein
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Regular	Regular	JJ	B-NP	O
insulin	insulin	NN	I-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

HCTZ	HCTZ	NN	B-NP	O
12.5	12.5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
7	7	CD	I-NP	O
.	.	.	O	O

Toprol	Toprol	NN	B-NP	B-protein
50	50	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
p.o.	p.o.	NN	I-NP	I-protein
q.d.	q.d.	NN	I-NP	I-protein
8	8	CD	I-NP	I-protein
.	.	.	O	O

Vitamin	Vitamin	NN	B-NP	O
B12	B12	NN	I-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Fosamax	Fosamax	NN	B-NP	O
35	35	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
week	week	NN	I-NP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

Protonix	Protonix	NNP	B-NP	O
.	.	.	O	O

11	11	CD	B-NP	O
.	.	.	O	O

Isordil	Isordil	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
12	12	CD	I-NP	O
.	.	.	O	O

Aspirin	Aspirin	NN	B-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
13	13	CD	I-NP	O
.	.	.	O	O

Flovent	Flovent	NNP	B-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Diltiazem	Diltiazem	NNP	B-NP	O
leads	lead	VBZ	B-VP	O
to	to	TO	I-VP	O
slow	slow	VB	I-VP	O
junctional	junctional	JJ	B-NP	O
rhythm	rhythm	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Quinine	Quinine	NN	B-NP	O
leads	lead	VBZ	B-VP	O
to	to	TO	I-VP	O
headache	headache	VB	I-VP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	NN	B-NP	O
EXAM	EXAM	NN	I-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Temperature	Temperature	NN	B-NP	O
97	97	CD	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
106/52	106/52	CD	I-NP	O
,	,	,	O	O
pulse	pulse	NN	B-NP	O
63	63	CD	I-NP	O
,	,	,	O	O
respiratory	respiratory	JJ	B-NP	O
rate	rate	NN	I-NP	O
16	16	CD	I-NP	O
,	,	,	O	O
saturation	saturation	NN	B-NP	O
94	94	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
2	2	CD	B-NP	O
liters	liter	NNS	I-NP	O
-LRB-	-LRB-	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
desaturated	desaturate	VBD	B-VP	O
to	to	TO	B-PP	O
84	84	CD	B-NP	O
%	%	NN	I-NP	O
with	with	IN	B-PP	O
minimal	minimal	JJ	B-NP	B-protein
movement	movement	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

In	In	IN	B-PP	O
general	general	JJ	B-NP	O
,	,	,	I-NP	O
obese	obese	JJ	I-NP	O
,	,	,	I-NP	O
tachypneic	tachypneic	JJ	I-NP	O
,	,	,	I-NP	O
ill-appearing	ill-appearing	JJ	I-NP	O
woman	woman	NN	I-NP	O
.	.	.	O	O

Neck	Neck	NN	B-NP	O
veins	vein	NNS	I-NP	O
difficult	difficult	JJ	B-ADJP	O
to	to	TO	B-VP	O
assess	assess	VB	I-VP	O
.	.	.	O	O

CVS	CVS	NN	B-NP	O
,	,	,	O	O
distant	distant	JJ	B-NP	O
heart	heart	NN	I-NP	O
sounds	sound	NNS	I-NP	O
.	.	.	O	O

Pulmonary	Pulmonary	JJ	B-NP	O
,	,	,	I-NP	O
bibasilar	bibasilar	JJ	I-NP	O
rales	rale	NNS	I-NP	O
.	.	.	O	O

Abdomen	Abdoman	NNS	B-NP	O
,	,	,	O	O
obese	obese	JJ	B-NP	O
,	,	,	I-NP	O
nontender	nontender	JJ	I-NP	O
,	,	,	I-NP	O
nondistended	nondistended	JJ	I-NP	O
with	with	IN	B-PP	O
positive	positive	JJ	B-NP	O
bowel	bowel	NN	I-NP	O
sounds	sound	NNS	I-NP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
+	+	SYM	I-NP	O
bilateral	bilateral	JJ	I-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

Neuro	Neuro	RB	B-ADVP	O
,	,	,	O	O
alert	alert	JJ	B-NP	O
and	and	CC	I-NP	O
oriented	orient	VBN	I-NP	O
x3	x3	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
focal	focal	JJ	I-NP	O
deficits	deficit	NNS	I-NP	O
.	.	.	O	O

Labs	Lab	NNS	B-NP	B-protein
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
were	be	VBD	B-VP	O
significant	significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
white	white	JJ	B-NP	O
blood	blood	NN	I-NP	O
cell	cell	NN	I-NP	O
count	count	NN	I-NP	O
equal	equal	JJ	B-ADJP	O
to	to	TO	B-PP	O
12	12	CD	B-NP	O
with	with	IN	B-PP	O
25	25	CD	B-NP	O
%	%	NN	I-NP	O
bands	band	NNS	I-NP	O
and	and	CC	O	O
56	56	CD	B-NP	O
%	%	NN	I-NP	O
polys	poly	NNS	I-NP	O
,	,	,	O	O
troponin	troponin	NN	B-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
0.19	0.19	CD	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

ID	ID	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
decreased	decrease	VBN	I-NP	O
O2	O2	NN	I-NP	O
saturation	saturation	NN	I-NP	O
,	,	,	O	O
chest	chest	NN	B-NP	O
x-ray	x-ray	NN	I-NP	O
findings	finding	NNS	I-NP	O
were	be	VBD	B-VP	O
all	all	DT	O	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
left	left	JJ	I-NP	O
lower	low	JJR	I-NP	O
lobe	lobe	NN	I-NP	O
pneumonia	pneumonia	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
Levaquin	Levaquin	NNP	B-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
seven-day	seven-day	JJ	I-NP	O
course	course	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
Levaquin	Levaquin	NN	I-NP	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
on	on	IN	B-PP	O
1/25/04	1/25/04	CD	B-NP	O
after	after	IN	B-PP	O
a	a	DT	B-NP	O
chest	chest	NN	I-NP	O
CT	CT	NN	I-NP	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
any	any	DT	B-NP	O
further	further	JJ	I-NP	O
infiltrate	infiltrate	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
lower	low	JJR	I-NP	O
lobe	lobe	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
weaned	wean	VBN	I-VP	O
off	off	RP	B-PRT	O
of	of	IN	B-PP	O
oxygen	oxygen	NN	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
saturating	saturate	VBG	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
high	high	JJ	I-NP	O
90	90	CD	I-NP	O
%	%	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
also	also	RB	B-ADVP	O
underwent	undergo	VBD	B-VP	O
urine	urine	NN	B-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
sputum	sputum	NN	B-NP	O
cultures	culture	NNS	I-NP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
growth	growth	NN	I-NP	O
of	of	IN	B-PP	O
any	any	DT	B-NP	O
organism	organism	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Pulmonary	Pulmonary	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
left	left	JJ	B-NP	O
upper	upper	JJ	I-NP	O
lobe	lobe	NN	I-NP	O
lung	lung	NN	I-NP	O
cancer	cancer	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
resection	resection	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
Flovent	Flovent	NN	I-NP	O
for	for	IN	B-PP	O
management	management	NN	B-NP	O
of	of	IN	B-PP	O
likely	likely	JJ	B-NP	O
COPD	COPD	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
a	a	DT	B-NP	O
chest	chest	NN	I-NP	O
CT	CT	NN	I-NP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
a	a	DT	B-NP	O
mass	mass	NN	I-NP	O
or	or	CC	I-NP	O
recurrence	recurrence	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
lung	lung	NN	I-NP	O
cancer	cancer	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Ischemia	Ischemia	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
troponin	troponin	NN	I-NP	O
as	as	RB	B-ADJP	O
high	high	JJ	I-ADJP	O
as	as	IN	B-PP	O
23	23	CD	B-NP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
and	and	CC	O	O
ruled	rule	VBN	B-VP	O
in	in	IN	B-PP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
non-NSTEMI	non-NSTEMI	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
hypoxemia	hypoxemia	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
aspirin	aspirin	NN	B-NP	O
,	,	,	O	O
statin	statin	NN	B-NP	O
beta-blocker	beta-blocker	NN	I-NP	O
and	and	CC	O	O
Ace	Ace	NN	B-NP	O
inhibitor	inhibitor	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
a	a	DT	B-NP	O
dobutamine	dobutamine	NN	I-NP	O
MIBI	MIBI	NN	I-NP	O
on	on	IN	B-PP	O
5/18/05	5/18/05	CD	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
areas	area	NNS	B-NP	O
of	of	IN	B-PP	O
periinfarct	periinfarct	NN	B-NP	O
ischemia	ischemia	NN	I-NP	O
most	most	RBS	B-ADJP	O
prominent	prominent	JJ	I-ADJP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
anterior	anterior	JJ	I-NP	O
wall	wall	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
then	then	RB	B-ADVP	O
underwent	undergo	VBD	B-VP	O
a	a	DT	B-NP	O
cardiac	cardiac	JJ	I-NP	O
catheterization	catheterization	NN	I-NP	O
on	on	IN	B-PP	O
11/29/05	11/29/05	CD	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
left	left	JJ	B-NP	O
main	main	JJ	I-NP	O
disease	disease	NN	I-NP	O
at	at	IN	B-PP	O
50	50	CD	B-NP	O
%	%	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
tight	tight	JJ	B-NP	O
left	left	JJ	I-NP	O
circumferential	circumferential	JJ	I-NP	O
LAD	LAD	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
100	100	CD	I-NP	O
%	%	NN	I-NP	O
RCA	RCA	NN	I-NP	O
lesion	lesion	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
then	then	RB	I-VP	O
evaluated	evaluate	VBN	I-VP	O
for	for	IN	B-PP	O
CABG	CABG	NN	B-NP	B-protein
in	in	IN	B-PP	O
light	light	NN	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
three-vessel	three-vessel	JJ	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

Due	Due	JJ	B-ADJP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
multiple	multiple	JJ	I-NP	O
comorbidities	comorbidity	NNS	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
a	a	DT	B-NP	O
preoperative	preoperative	JJ	I-NP	O
evaluation	evaluation	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
chest	chest	NN	I-NP	O
CT	CT	NN	I-NP	O
,	,	,	O	O
carotid	carotid	NN	B-NP	O
ultrasound	ultrasound	NN	I-NP	O
,	,	,	O	O
pulmonary	pulmonary	JJ	B-NP	O
function	function	NN	I-NP	O
test	test	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
echocardiogram	echocardiogram	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
chest	chest	NN	I-NP	O
CT	CT	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
lung	lung	NN	B-NP	O
cancer	cancer	NN	I-NP	O
recurrence	recurrence	NN	I-NP	O
.	.	.	O	O

Carotid	Carotid	JJ	B-NP	O
ultrasound	ultrasound	NN	I-NP	O
was	be	VBD	B-VP	O
significant	significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
bilateral	bilateral	JJ	B-NP	O
ICA	ICA	NN	I-NP	O
stenosis	stenosis	NN	I-NP	O
at	at	IN	B-PP	O
60	60	CD	B-NP	O
%	%	NN	I-NP	O
-65	-65	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

PFT	PFT	NN	B-NP	O
showed	show	VBD	B-VP	O
an	an	DT	B-NP	O
FEV1	FEV1	NN	I-NP	O
of	of	IN	B-PP	O
1.2	1.2	CD	B-NP	O
liters	liter	NNS	I-NP	O
or	or	CC	O	O
61	61	CD	B-NP	O
%	%	NN	I-NP	O
predicted	predict	VBN	B-VP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
FEV1/FVC	FEV1/FVC	NN	I-NP	O
ratio	ratio	NN	I-NP	O
at	at	IN	B-PP	O
84	84	CD	B-NP	O
%	%	NN	I-NP	O
predicted	predict	VBN	B-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
echo	echo	NN	I-NP	O
showed	show	VBD	B-VP	O
an	an	DT	B-NP	O
EF	EF	NN	I-NP	B-protein
of	of	IN	B-PP	O
55	55	CD	B-NP	O
%	%	NN	I-NP	O
with	with	IN	B-PP	O
mild	mild	JJ	B-NP	O
LVH	LVH	NN	I-NP	O
,	,	,	O	O
mild	mild	JJ	B-NP	O
hypokinesis	hypokinesis	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
inferior	inferior	JJ	I-NP	O
base	base	NN	I-NP	O
and	and	CC	I-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
diastolic	diastolic	JJ	B-NP	O
dysfunction	dysfunction	NN	I-NP	O
.	.	.	O	O

Based	Base	VBN	B-PP	O
on	on	IN	B-PP	O
these	these	DT	B-NP	O
test	test	NN	I-NP	O
results	result	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
deemed	deem	VBN	I-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
undergo	undergo	VB	I-VP	O
CABG	CABG	NN	B-NP	B-protein
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
surgery	surgery	NN	I-NP	O
was	be	VBD	B-VP	O
scheduled	schedule	VBN	I-VP	O
for	for	IN	B-PP	O
6/19/05	6/19/05	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
underwent	undergo	VBD	B-VP	O
preoperative	preoperative	JJ	B-NP	O
evaluation	evaluation	NN	I-NP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
cardiac	cardiac	JJ	I-NP	O
surgery	surgery	NN	I-NP	O
team	team	NN	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
4/29/05	4/29/05	CD	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Pump	Pump	NNP	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
volume	volume	NN	B-NP	O
overloaded	overload	VBD	B-VP	O
given	give	VBN	I-VP	O
her	her	PRP$	B-NP	O
exam	exam	NN	I-NP	O
and	and	CC	I-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
findings	finding	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
one	one	CD	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
Lasix	Lasix	NN	B-NP	O
at	at	IN	B-PP	O
20	20	CD	B-NP	O
mg	mg	NN	I-NP	O
IV	IV	CD	I-NP	O
and	and	CC	O	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
adequate	adequate	JJ	I-NP	O
diuresis	diuresis	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
considered	consider	VBN	I-VP	O
euvolemic	euvolemic	JJ	B-ADJP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
rest	rest	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
admission	admission	NN	I-NP	O
and	and	CC	O	O
required	require	VBD	B-VP	O
no	no	DT	B-NP	O
additional	additional	JJ	I-NP	O
doses	dose	NNS	I-NP	O
of	of	IN	B-PP	O
Lasix	Lasix	NNP	B-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Rhythm	Rhythm	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
kept	keep	VBN	I-VP	O
on	on	IN	B-PP	O
telemetry	telemetry	NN	B-NP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
were	be	VBD	B-VP	O
no	no	DT	B-NP	O
significant	significant	JJ	I-NP	O
events	event	NNS	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
EKG	EKG	NN	I-NP	O
changes	change	NNS	I-NP	O
outside	outside	JJ	B-ADJP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
increasing	increase	VBG	I-NP	O
ST	ST	NN	I-NP	O
depression	depression	NN	I-NP	O
as	as	IN	B-SBAR	O
seen	see	VBN	B-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
admission	admission	NN	I-NP	O
EKG	EKG	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Renal	Renal	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
initial	initial	JJ	I-NP	O
creatinine	creatinine	NN	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
was	be	VBD	B-VP	O
elevated	elevate	VBN	I-VP	O
at	at	IN	B-PP	O
1.6	1.6	CD	B-NP	O
from	from	IN	B-PP	O
her	her	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
of	of	IN	B-PP	O
1.2	1.2	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
creatinine	creatinine	NN	I-NP	O
trended	trend	VBD	B-VP	O
down	down	RB	B-ADVP	O
to	to	TO	B-PP	O
1.36	1.36	CD	B-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
admission	admission	NN	I-NP	O
and	and	CC	O	O
remained	remain	VBD	B-VP	O
around	around	IN	B-PP	O
her	her	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
until	until	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
was	be	VBD	B-VP	O
closely	closely	RB	I-VP	O
monitored	monitor	VBN	I-VP	O
after	after	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
received	receive	VBD	B-VP	O
mucomyst	mucomyst	NN	B-NP	O
and	and	CC	O	O
IV	IV	CD	B-NP	O
fluids	fluid	NNS	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
catheterization	catheterization	NN	B-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Endocrine	Endocrine	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
NPH	NPH	NN	I-NP	B-protein
and	and	CC	O	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	B-protein
insulin	insulin	NN	I-NP	I-protein
during	during	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
an	an	DT	B-NP	O
enlarged	enlarged	JJ	I-NP	O
thyroid	thyroid	NN	I-NP	O
on	on	IN	B-PP	O
chest	chest	NN	B-NP	O
CT.	CT.	NNP	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
TSH	TSH	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
normal	normal	JJ	B-ADJP	O
at	at	IN	B-PP	O
3.125	3.125	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
thyroid	thyroid	JJ	I-NP	O
function	function	NN	I-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Rheumatology	Rheumatology	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
PMR	PMR	NN	B-NP	B-protein
and	and	CC	O	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
prednisone	prednisone	NN	I-NP	O
dose	dose	NN	I-NP	O
at	at	IN	B-PP	O
10	10	CD	B-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
9	9	CD	I-NP	O
.	.	.	O	O

Code	Code	NN	B-NP	O
status	status	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
remained	remain	VBD	B-VP	O
a	a	DT	B-NP	O
full	full	JJ	I-NP	O
code	code	NN	I-NP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
AT	AT	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Tylenol	Tylenol	NN	B-NP	O
650	650	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
4h	4h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	LS	B-NP	O
headache	headache	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Aspirin	Aspirin	NN	B-NP	O
81	81	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
3	3	CD	I-NP	O
.	.	.	O	O

Dulcolax	Dulcolax	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	FW	I-NP	O
p.r.n.	p.r.n.	FW	I-NP	O
constipation	constipation	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Colace	Colace	NNP	B-NP	O
100mg	100mg	CD	I-NP	O
p.o.	p.o.	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
5	5	CD	I-NP	O
.	.	.	O	O

Hydralazine	Hydralazine	NN	B-NP	B-protein
20	20	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
p.o.	p.o.	NN	I-NP	I-protein
t.i.d.	t.i.d.	NN	I-NP	I-protein
6	6	CD	I-NP	I-protein
.	.	.	O	O

NPH	NPH	NN	B-NP	B-protein
insulin	insulin	NN	I-NP	I-protein
30	30	CD	B-NP	I-protein
units	unit	NNS	I-NP	I-protein
,	,	,	O	O
16	16	CD	B-NP	O
units	unit	NNS	I-NP	O
q.p.m.	q.p.m.	RB	B-ADJP	O
subcutaneous	subcutaneous	JJ	I-ADJP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Lisinopril	Lisinopril	NNP	B-NP	O
60	60	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
8	8	CD	I-NP	O
.	.	.	O	O

Prednisone	Prednisone	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
9	9	CD	I-NP	O
.	.	.	O	O

Flovent	Flovent	NN	B-NP	O
44	44	CD	I-NP	O
mcg	mcg	NN	I-NP	O
inhaled	inhale	VBD	B-VP	O
b.i.d.	b.i.d.	NN	B-NP	O
10	10	CD	I-NP	O
.	.	.	O	O

Fosamax	Fosamax	NN	B-NP	O
35	35	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
week	week	NN	I-NP	O
.	.	.	O	O

11	11	CD	B-NP	O
.	.	.	O	O

Atorvastatin	Atorvastatin	NN	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
12	12	CD	I-NP	O
.	.	.	O	O

Imdur	Imdur	NN	B-NP	O
90	90	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
13	13	CD	I-NP	O
.	.	.	O	O

Toprol	Toprol	NN	B-NP	O
XL	XL	NN	I-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
14	14	CD	I-NP	O
.	.	.	O	O

Protonix	Protonix	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
15	15	CD	I-NP	O
.	.	.	O	O

Vicodin	Vicodin	NN	B-NP	O
one	one	CD	I-NP	O
tablet	tablet	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.	q.	NN	I-NP	O
4h	4h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	LS	B-NP	O
back	back	JJ	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

FOLLOW-UP	FOLLOW-UP	JJ	B-NP	O
PLAN	PLAN	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	O
surgery	surgery	NN	I-NP	O
on	on	IN	B-PP	O
10/24/05	10/24/05	CD	B-NP	O
for	for	IN	B-PP	O
admission	admission	NN	B-NP	O
for	for	IN	B-PP	O
CABG	CABG	NN	B-NP	B-protein
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
also	also	RB	I-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Evan	Evan	NNP	I-NP	O
Rendon	Rendon	NNP	I-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
doctor	doctor	NN	I-NP	O
on	on	IN	B-PP	O
6/9/05	6/9/05	CD	B-NP	O
at	at	IN	B-PP	O
8.30	8.30	CD	B-NP	O
a.m.	a.m.	RB	I-NP	O
eScription	eScription	NN	I-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
4-1160642	4-1160642	CD	B-NP	O
EMSSten	EMSSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
JUEL	JUEL	NNP	B-NP	O
,	,	,	O	O
ARCHIE	ARCHIE	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
HILDEN	HILDEN	NN	B-NP	O
,	,	,	O	O
ALFRED	ALFRED	NNP	B-NP	O
HUNTER	HUNTER	NNP	I-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
5508419	5508419	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
9/15/05	9/15/05	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
9/15/05	9/15/05	CD	B-NP	O

